Nancy Berg CEO, ISPOR Nancy Berg has nearly 30 years of experience in health care, scientific, and technical association leadership, and has been an entrepreneur and business consultant to both commercial and nonprofit organizations. Ms Berg has been chief executive officer (CEO) and executive director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) [...]
September 30th, 18.00 - 19.30 - Live Webcast from the European Health Forum Gastein
This session is organised in partnership with:
David A. Dworaczyk, Ph.D. Director, Life and Health Sciences Strategic Development, Oracle Health Sciences Dr. Dworaczyk has done extensive work with numerous Healthcare, Pharma, Biotech, Diagnostic and CRO focused Venture and Private Equity investment groups assessing and evaluating investment opportunities from an operational, strategic and business potential perspective. He is currently the Director of Life [...]
John Peter Mary Wubbe Secretary General & Independent board member, Epossi John Peter Mary Wubbe is a healthcare professional, have studied MSc European Public Health, specializing in Governance. Mr. Wubbe has created EuDiPPA to improve data governance. Mr Wubbe expertise lies in Genomics-Robotics-Informatics-Biometrics (GRIBs) and Phenotype and Genotype Datasets. He is deeply knowledgeable in the [...]
Pierre Meulien Executive Director, Innovative Medicines Initiative Pierre Meulien joined IMI as Executive Director in September 2015. Prior to that Pierre Meulien was President and Chief Executive Officer (CEO) of Genome Canada, a not-for-profit organisation that connects ideas and people across public and private sectors to find new uses for genomics and invests in large-scale [...]
Sabine Atzor Director Regulatory Affairs, part time seconded from F.Hoffmann-La Roche to EFPIA Sabine Atzor joined F. Hoffmann-La Roche Ltd in Basel as Head of EU Regulatory Policies in 2010. In this function she has been contributing to various policy discussions within EFPIA, in particular on the new EU Clinical Trials Regulation, where she has [...]
Sandra A. Milligan, MD, JD President, DIA Senior Vice President, Head of Regulatory Affairs and Safety Merck Research Laboratories Dr. Milligan currently serves as Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety of Merck, consisting of the global Regulatory, Safety and CMC functions of Merck Research Laboratories. She previously served as [...]
Better Science, Better Health: New Healthcare Models - Washington, DC 27th-28th October Request your invitation! * required First Name: * Last Name: * Jobtitle: * Company Name: * Email Address: *
Dainius Pavalkis Professor, Lithuanian University of Health Sciences Dainius Pavalkis, professor Lithuanian university of health sciences. 1995-2005 was Director for surgery of the biggest in Lithuanian University hospital – Kauno Klinikos – with responsibility for all clinical and administrative activities of all surgical specialties, intensive care and trauma. As professor of the university, he published [...]
Mark Pearson Deputy Director for Employment Labour and Social Affairs, Organisation for Economic Co-operation and Development (OECD) Mark Pearson is Deputy Director for Employment Labour and Social Affairs at the Organisation for Economic Co-operation and Development (OECD) where he helps countries to improve their health systems by providing internationally comparable data, state-of-the-art analysis and appropriate [...]